Home
Journal Information
About
Aims and Scope
Contact Us
Editorial Board
Editor in Chief
Editorial Policies
Publication Ethics
Indexing/Abstracting
Peer review prosess
Publication Fee
Publisher
Editorial Board Policy
Human and Animal Rights
Journal Issues
Current Issue
In Press
All Issues
Guidelines
For Authors
For Reviewers
Call for Papers
Editorial Workflow
Implications
Informed Consent
Checklist for Review
Disclaimer
Conflicts of Interests
Create Account
Login
Title
Author
Abstract
Keywords
First Name
Last Name
Search
eISSN
:
2345-5004
J Herbmed Pharmacol
. 2022;11(2): 154-165. doi:
10.34172/jhp.2022.20
Review
Potential pharmacokinetic and pharmacodynamic herb-drug interactions of Andrographis paniculata (Burm. f.) and andrographolide: A systematic review
Elza Sundhani
1
,
2
, Endang Lukitaningsih
3
, Arief Nurrochmad
4
, Agung Endro Nugroho
4
*
Cited by CrossRef: 3
1- Feng Y, Xiao P, Liu Z, Li M, Wang Q, Yin T, Zhang Y, He H, Gou J, Wang Y, Tang X. Reducing allergic reaction and enhancing anti-inflammatory effect of dehydroandrographolide through dehydroandrographolide prodrug liposomes.
Journal of Drug Delivery Science and Technology
. 2023;88:104928
[Crossref]
2- Sundhani E, Nugroho A, Nurrochmad A, Puspitasari I, Amalia Prihati D, Lukitaningsih E. Pharmacokinetic Herb-Drug Interactions of Glipizide with Andrographis paniculata (Burm. f.) and Andrographolide in Normal and Diabetic Rats by Validated HPLC Method.
Molecules
. 2022;27(20):6901
[Crossref]
3- Smith D, Bi H, Hamman J, Ma X, Mitchell C, Nyirenda K, Monera-Penduka T, Oketch-Rabah H, Paine M, Pettit S, Pheiffer W, Van Breemen R, Embry M. Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countries.
Front Pharmacol
. 2023;14
[Crossref]
Submit Your Paper
Editorial Board
Aims and Scope
Editorial Policies
Ethics
Contact Us
Archive
2.7
2022
CiteScore
29th percentile
Powered by